Birgit Gruenberger

Summary

Country: Austria

Publications

  1. doi request reprint Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study
    Birgit Gruenberger
    Department of Internal Medicine, Barmherzige Brueder Hospital Vienna, Vienna, Austria
    Lancet Oncol 11:1142-8. 2010
  2. pmc Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
    Birgit Gruenberger
    Department of Medicine, Medical University Vienna, Vienna, Austria
    BMC Cancer 8:120. 2008
  3. doi request reprint Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy
    Dietmar Tamandl
    Department of Surgery, Medical University of Vienna, Vienna, Austria
    Ann Surg Oncol 18:421-30. 2011
  4. doi request reprint Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX
    Markus Klinger
    Department of General Surgery, Hepatobiliary Service, Medical University of Vienna, Vienna, Austria
    Ann Surg Oncol 17:2059-65. 2010
  5. doi request reprint Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study
    Dietmar Tamandl
    Department of Surgery, Medical University of Vienna, Vienna, Austria
    Ann Surg 252:124-30. 2010
  6. doi request reprint Surgery after neoadjuvant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients
    Dietmar Tamandl
    Department of Surgery, Hepatobiliary Service, Medical University Vienna, Vienna, Austria
    J Surg Oncol 100:364-71. 2009
  7. doi request reprint Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases
    Dietmar Tamandl
    Department of Surgery, Medical University of Vienna, Vienna, Austria
    Surgery 143:648-57. 2008
  8. doi request reprint Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma
    Dietmar Tamandl
    Department of Surgery, Hepatobiliary Service, Medical University of Vienna, Waehringer Guertel 18 20, 1090, Vienna, Austria
    Ann Surg Oncol 15:2787-94. 2008
  9. pmc Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction
    Stefanie Haegele
    Department of Surgery, Medical University of Vienna, General Hospital, Vienna, Austria
    PLoS ONE 10:e0116985. 2015
  10. doi request reprint Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels
    Christine Brostjan
    Medical University of Vienna, Department of Surgery, General Hospital, Vienna, Austria
    Clin Cancer Res 14:2065-74. 2008

Collaborators

Detail Information

Publications15

  1. doi request reprint Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study
    Birgit Gruenberger
    Department of Internal Medicine, Barmherzige Brueder Hospital Vienna, Vienna, Austria
    Lancet Oncol 11:1142-8. 2010
    ..We aimed to investigate the efficacy and safety of cetuximab in combination with gemcitabine and oxaliplatin (GEMOX) for first-line treatment of biliary tract cancer...
  2. pmc Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
    Birgit Gruenberger
    Department of Medicine, Medical University Vienna, Vienna, Austria
    BMC Cancer 8:120. 2008
    ..We prospectively investigated whether neoadjuvant chemotherapy reduces the risk of recurrence following potentially curative liver resection. Special emphasis was directed to the importance of response...
  3. doi request reprint Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy
    Dietmar Tamandl
    Department of Surgery, Medical University of Vienna, Vienna, Austria
    Ann Surg Oncol 18:421-30. 2011
    ..We investigated whether liver damage had further implications on long-term outcome in these patients...
  4. doi request reprint Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX
    Markus Klinger
    Department of General Surgery, Hepatobiliary Service, Medical University of Vienna, Vienna, Austria
    Ann Surg Oncol 17:2059-65. 2010
    ..The knowledge about the effect of bevacizumab, if given in addition to fluoropyrimidines and oxaliplatin, on tumor regression and its consequences on clinical outcome is limited...
  5. doi request reprint Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study
    Dietmar Tamandl
    Department of Surgery, Medical University of Vienna, Vienna, Austria
    Ann Surg 252:124-30. 2010
    ..Parameters contributing to an increased morbidity were evaluated...
  6. doi request reprint Surgery after neoadjuvant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients
    Dietmar Tamandl
    Department of Surgery, Hepatobiliary Service, Medical University Vienna, Vienna, Austria
    J Surg Oncol 100:364-71. 2009
    ..Neoadjuvant chemotherapy increases progression free survival in resectable patients. The safety and feasibility of this concept has not been investigated in elderly patients...
  7. doi request reprint Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases
    Dietmar Tamandl
    Department of Surgery, Medical University of Vienna, Vienna, Austria
    Surgery 143:648-57. 2008
    ..We investigated the value of preoperative staging on detection of additional resectable hepatic lesions in metastatic colorectal cancer patients...
  8. doi request reprint Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma
    Dietmar Tamandl
    Department of Surgery, Hepatobiliary Service, Medical University of Vienna, Waehringer Guertel 18 20, 1090, Vienna, Austria
    Ann Surg Oncol 15:2787-94. 2008
    ..We analyzed whether hepatic resection margin is a prognostic factor for local or distant recurrence and survival in patients resected with curative intent...
  9. pmc Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction
    Stefanie Haegele
    Department of Surgery, Medical University of Vienna, General Hospital, Vienna, Austria
    PLoS ONE 10:e0116985. 2015
    ..With this investigation we aimed to determine if perioperative TPO levels were associated with postoperative outcome in patients undergoing liver resection...
  10. doi request reprint Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels
    Christine Brostjan
    Medical University of Vienna, Department of Surgery, General Hospital, Vienna, Austria
    Clin Cancer Res 14:2065-74. 2008
    ..We characterized the systemic angiogenic balance in the perioperative period to evaluate its effect on physiologic angiogenesis...
  11. doi request reprint CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases
    Stefan Stremitzer
    Department of General Surgery, Medical University Vienna, Vienna, Austria
    Ann Surg Oncol 22:1315-23. 2015
    ..To address this issue, the value of carcinoembryonic antigen (CEA) change after neoadjuvant chemotherapy was investigated to predict clinical outcome in this study...
  12. doi request reprint Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans
    Patrick Starlinger
    Department of Surgery, Medical University of Vienna, General Hospital, Vienna, Austria
    Hepatology 60:257-66. 2014
    ..045 and P = 0.021) and were able to demonstrate that IP 5-HT levels were an independent predictor of poor clinical outcome...
  13. ncbi request reprint Clinical pharmacokinetics of capecitabine and its metabolites in combination with the monoclonal antibody bevacizumab
    Andre Farkouh
    Division of Clinical Pharmacy and Diagnostics, Faculty of Life Sciences, University of Vienna, Vienna, Austria Austrian Society of Applied Pharmacokinetics, Vienna, Austria
    Anticancer Res 34:3669-73. 2014
    ..This study was designed to investigate whether co-administration of the monoclonal antibody bevacizumab (BVZ) shows potential to modulate the plasma disposition of capecitabine (CCB) and its metabolites...
  14. ncbi request reprint Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma
    Beata Herberger
    Department of Medicine I, Medical University of Vienna, Vienna, Austria
    Clin Cancer Res 13:4795-9. 2007
    ..The purpose of our study was to determine the prognostic value of activated mTOR (p-mTOR) in patients with biliary tract adenocarcinoma (BTA), in order to strengthen the rationale for targeted therapy of BTA using mTOR inhibitors...
  15. ncbi request reprint Assessment of the role of hepatitis C, Helicobacter pylori and autoimmunity in MALT lymphoma of the ocular adnexa in 45 Austrian patients
    Birgit Gruenberger
    Department of Medicine I, Medical University Vienna, Vienna, Austria
    Acta Oncol 47:355-9. 2008
    ..A recent series from Italy has suggested a pathogenic link between hepatitis C virus and MALT lymphoma of the ocular adnexa. The hypothesis of our study was to prove this concept in Austrian patients with MALT lymphoma of the ocular adnexa...